KATY COCHRAN: Open Payments
NPI 1710484159 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,563 in 141 payments from 21 companies in 2025. Trend: 2023 $367 · 2024 $538 · 2025 $2,563
Food & beverage: $2,563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $820 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $370 |
| Janssen Biotech, Inc. | 20 | $252 |
| Madrigal Pharmaceuticals | 10 | $183 |
| Ardelyx, Inc. | 9 | $167 |
| PFIZER INC. | 9 | $139 |
| Phathom Pharmaceuticals, Inc. | 8 | $95 |
| Aimmune Therapeutics, Inc. | 3 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| Celltrion USA Inc. | 3 | $62 |
Products named: RINVOQ, ENTYVIO, TREMFYA, REZDIFFRA, IBSRELA, SKYRIZI, VOQUEZNA, CREON.
Industry payments across TX — which companies pay providers there.
